Cargando…
Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules
[Image: see text] Major advances have recently defined functions for human mono-ADP-ribosylating PARP enzymes (mono-ARTs), also opening up potential applications for targeting them to treat diseases. Structural biology combined with medicinal chemistry has allowed the design of potent small molecule...
Autores principales: | Nizi, Maria Giulia, Maksimainen, Mirko M., Lehtiö, Lari, Tabarrini, Oriana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189837/ https://www.ncbi.nlm.nih.gov/pubmed/35608571 http://dx.doi.org/10.1021/acs.jmedchem.2c00281 |
Ejemplares similares
-
Privileged Scaffolds for Potent and Specific Inhibitors of Mono-ADP-Ribosylating PARPs
por: Nizi, Maria Giulia, et al.
Publicado: (2023) -
A molecular toolbox for ADP-ribosyl binding proteins
por: Sowa, Sven T., et al.
Publicado: (2021) -
Evaluation of 3‐ and 4‐Phenoxybenzamides as Selective Inhibitors of the Mono‐ADP‐Ribosyltransferase PARP10
por: Korn, Patricia, et al.
Publicado: (2021) -
Mono-ADP-ribosylation by PARP10 and PARP14 in genome stability
por: Dhoonmoon, Ashna, et al.
Publicado: (2023) -
Preparation of screening assays for ADP-ribosyl readers and erasers using the GAP-tag as a binding probe
por: Sowa, Sven T., et al.
Publicado: (2022)